215 related articles for article (PubMed ID: 29490165)
1. The Immune Response to Mycobacterium tuberculosis in HIV-1-Coinfected Persons.
Esmail H; Riou C; Bruyn ED; Lai RP; Harley YXR; Meintjes G; Wilkinson KA; Wilkinson RJ
Annu Rev Immunol; 2018 Apr; 36():603-638. PubMed ID: 29490165
[TBL] [Abstract][Full Text] [Related]
2. Immune variations throughout the course of tuberculosis treatment and its relationship with adrenal hormone changes in HIV-1 patients co-infected with Mycobacterium tuberculosis.
Vecchione MB; Angerami MT; Suarez GV; Turk G; Laufer N; Ben G; Ameri D; Gonzalez D; Parodi LM; Giavedoni LD; Maidana P; Fabre B; Mesch V; Sued O; Quiroga MF
Tuberculosis (Edinb); 2021 Mar; 127():102045. PubMed ID: 33434785
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 tuberculosis-associated immune reconstitution inflammatory syndrome.
Lai RP; Meintjes G; Wilkinson RJ
Semin Immunopathol; 2016 Mar; 38(2):185-98. PubMed ID: 26423994
[TBL] [Abstract][Full Text] [Related]
4. HIV Interferes with Mycobacterium tuberculosis Antigen Presentation in Human Dendritic Cells.
Singh SK; Andersson AM; Ellegård R; Lindestam Arlehamn CS; Sette A; Larsson M; Stendahl O; Blomgran R
Am J Pathol; 2016 Dec; 186(12):3083-3093. PubMed ID: 27746182
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 and the Mycobacterium tuberculosis granuloma: A systematic review and meta-analysis.
Diedrich CR; O'Hern J; Wilkinson RJ
Tuberculosis (Edinb); 2016 May; 98():62-76. PubMed ID: 27156620
[TBL] [Abstract][Full Text] [Related]
6. The effect of antiretroviral treatment on selected genes in whole blood from HIV-infected adults sensitised by Mycobacterium tuberculosis.
Jhilmeet N; Lowe DM; Riou C; Scriba TJ; Coussens A; Goliath R; Wilkinson RJ; Wilkinson KA
PLoS One; 2018; 13(12):e0209516. PubMed ID: 30589870
[TBL] [Abstract][Full Text] [Related]
7. Tuberculosis: Smart manipulation of a lethal host.
Chaurasiya SK
Microbiol Immunol; 2018 Jun; 62(6):361-379. PubMed ID: 29687912
[TBL] [Abstract][Full Text] [Related]
8. In Vivo Molecular Dissection of the Effects of HIV-1 in Active Tuberculosis.
Bell LC; Pollara G; Pascoe M; Tomlinson GS; Lehloenya RJ; Roe J; Meldau R; Miller RF; Ramsay A; Chain BM; Dheda K; Noursadeghi M
PLoS Pathog; 2016 Mar; 12(3):e1005469. PubMed ID: 26986567
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 Infection Is Associated with Depletion and Functional Impairment of
Day CL; Abrahams DA; Harris LD; van Rooyen M; Stone L; de Kock M; Hanekom WA
J Immunol; 2017 Sep; 199(6):2069-2080. PubMed ID: 28760884
[TBL] [Abstract][Full Text] [Related]
10. Monocytic-Myeloid Derived Suppressor Cells of HIV-Infected Individuals With Viral Suppression Exhibit Suppressed Innate Immunity to
Namdev P; Patel S; Sparling B; Garg A
Front Immunol; 2021; 12():647019. PubMed ID: 33995365
[TBL] [Abstract][Full Text] [Related]
11. Effects of helminths and Mycobacterium tuberculosis infection on HIV-1: a cellular immunological perspective.
Mouser EE; Pollakis G; Paxton WA
Curr Opin HIV AIDS; 2012 May; 7(3):260-7. PubMed ID: 22411452
[TBL] [Abstract][Full Text] [Related]
12. An observational study identifying highly tuberculosis-exposed, HIV-1-positive but persistently TB, tuberculin and IGRA negative persons with M. tuberculosis specific antibodies in Cape Town, South Africa.
Kroon EE; Kinnear CJ; Orlova M; Fischinger S; Shin S; Boolay S; Walzl G; Jacobs A; Wilkinson RJ; Alter G; Schurr E; Hoal EG; Möller M
EBioMedicine; 2020 Nov; 61():103053. PubMed ID: 33038764
[TBL] [Abstract][Full Text] [Related]
13. Repurposing Saquinavir for Host-Directed Therapy to Control Mycobacterium Tuberculosis Infection.
Pires D; Valente S; Calado M; Mandal M; Azevedo-Pereira JM; Anes E
Front Immunol; 2021; 12():647728. PubMed ID: 33841429
[TBL] [Abstract][Full Text] [Related]
14. T cells and adaptive immunity to Mycobacterium tuberculosis in humans.
Jasenosky LD; Scriba TJ; Hanekom WA; Goldfeld AE
Immunol Rev; 2015 Mar; 264(1):74-87. PubMed ID: 25703553
[TBL] [Abstract][Full Text] [Related]
15. Immunology of AIDS virus and mycobacterial co-infection.
Chen ZW
Curr HIV Res; 2004 Oct; 2(4):351-5. PubMed ID: 15544456
[TBL] [Abstract][Full Text] [Related]
16. The effect of tuberculosis on immune reconstitution among HIV patients on highly active antiretroviral therapy in Adigrat general hospital, eastern Tigrai, Ethiopia; 2019: a retrospective follow up study.
Negash H; Legese H; Tefera M; Mardu F; Tesfay K; Gebresilasie S; Fseha B; Kahsay T; Gebrewahd A; Berhe B
BMC Immunol; 2019 Dec; 20(1):45. PubMed ID: 31805857
[TBL] [Abstract][Full Text] [Related]
17. Relationship between chemokine receptor expression, chemokine levels and HIV-1 replication in the lungs of persons exposed to Mycobacterium tuberculosis.
Kalsdorf B; Skolimowska KH; Scriba TJ; Dawson R; Dheda K; Wood K; Hofmeister J; Hanekom WA; Lange C; Wilkinson RJ
Eur J Immunol; 2013 Feb; 43(2):540-9. PubMed ID: 23147374
[TBL] [Abstract][Full Text] [Related]
18. Systemic immune activation and microbial translocation in dual HIV/tuberculosis-infected subjects.
Toossi Z; Funderburg NT; Sirdeshmuk S; Whalen CC; Nanteza MW; Johnson DF; Mayanja-Kizza H; Hirsch CS
J Infect Dis; 2013 Jun; 207(12):1841-9. PubMed ID: 23479321
[TBL] [Abstract][Full Text] [Related]
19. Antiretroviral Treatment-Induced Decrease in Immune Activation Contributes to Reduced Susceptibility to Tuberculosis in HIV-1/Mtb Co-infected Persons.
Wilkinson KA; Schneider-Luftman D; Lai R; Barrington C; Jhilmeet N; Lowe DM; Kelly G; Wilkinson RJ
Front Immunol; 2021; 12():645446. PubMed ID: 33746987
[TBL] [Abstract][Full Text] [Related]
20. Microbiological investigation for tuberculosis among HIV-infected children in Soweto, South Africa.
Fairlie L; Muchiri E; Beylis CN; Meyers T; Moultrie H
Int J Tuberc Lung Dis; 2014 Jun; 18(6):676-81. PubMed ID: 24903938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
